Furthermore, we demonstrated that miR-591 could regulate cell proliferation and invasion by targeting TCF4 and inhibited the TCF4 and Hippo-YAP signaling, which may function as a potential target of breast cancer treatment. Here, YAP1 is linked to breast carcinoma.